China charges GSK-linked investigators for illegally obtaining private information 

gsk flutters next to a Chinese national flag outside a GlaxoSmithKline office building in Shanghai

Prosecutors in China have filed charges against British investigator Peter Humphrey and his American wife, the official Xinhua news agency said on Monday, after the couple were detained last year following work they did for British drugmaker GlaxoSmithKline Plc.

The case against Humphrey and his wife Yu Yingzeng has become a key piece in a long-running investigation into GSK, whose China executives have been charged with orchestrating a widespread network of bribery to promote sales.

The case against the couple, who have been accused of illegally obtaining private information, has been formally lodged with the Shanghai Number One Intermediate People’s Court for trial, the Xinhua report said.

Two family friends with knowledge of the matter told Reuters this month that the couple’s trial is set for Aug. 7 and will be closed to the public. The secrecy surrounding the trial has raised concern from British and U.S. officials. China’s foreign ministry said last week that the trial will be handled in accordance with the law.

ChinaWhys, the risk consultancy run by the couple, was employed by GSK in April 2013 to investigate an ex-employee suspected of sending anonymous emails, including the circulation of an intimate video of former GSK China head Mark Reilly with his girlfriend, as well as emails containing allegations of widespread bribery at the British drugmaker.

The Xinhua report said that Humphrey and Yu had paid people in Beijing and Shanghai to purchase personal information. Citing the prosecutor on the case, the report added that the couple had been fully aware of the illegality of their actions.

Between 2009 and 2013 the couple illegally obtained private information during investigations into close to a thousand firms and a large number of private individuals, including household registration data, real estate and vehicle documents, as well as phone records, it added.

Representatives for GSK could not be immediately reached for comment.

(Reporting by Adam Jourdan and Hui Li; Editing by Kazunori Takada and Edwina Gibbs)

Source: Reuters

Leave a Comment


Broker Cyprus TopFX